Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation

AKIMOTO T., 1999, Clinical Cancer Research, 5, 2884

10.1016/S0167-4889(96)00068-7

BLAGOSKLONNY M. V., 1995, Oncogene, 11, 933

BROGNARD J., 2001, Cancer Research, 61, 3986

10.1016/S0092-8674(00)80595-4

10.1126/science.282.5392.1318

10.1016/S0092-8674(00)80405-5

10.1002/ijc.2910510418

FREEMAN B. C., 1996, EMBO Journal, 15, 2969, 10.1002/j.1460-2075.1996.tb00660.x

10.1667/0033-7587(2000)153%5b0371:IRIMAP%5d2.0.CO;2

HYUN T., 2000, Blood, 96, 3560, 10.1182/blood.V96.10.3560

KUBOTA N., 1998, Cancer Letters, 133, 161, 10.1016/S0304-3835(98)00221-3

LI J., 1947, Science, 275, 1943–, 10.1126/science.275.5308.1943

MENDELSOHN J, 1997, Clinical Cancer Research, 3, 2703

MUNSTER P. N., 2001, Clinical Cancer Research, 7, 2228

10.1023/A:1006382320697

PIETRAS R. J., 1999, Cancer Research, 59, 1347

10.1038/43474

10.1126/science.3798106

SMITH D. F., 1998, Pharmacological Reviews, 50, 493

10.1016/S0092-8674(00)81780-8

STANCATO L. F., 1993, Journal of Biological Chemistry, 268, 21711, 10.1016/S0021-9258(20)80600-0

10.1016/S0092-8674(00)80203-2

10.1038/ng0497-356

Xu Y., 1993, Proceedings of the National Academy of Sciences, USA, 90, 7074, 10.1073/pnas.90.15.7074

XII W., 2001, Journal of Biological Chemistry, 276, 3702, 10.1074/jbc.M006864200